Pharmacokinetics, Safety, Tolerability & Pharmacodynamics of BMS-986189 in

See also
Status	Clinical Trial	Phase
Completed	`NCT04804306` - Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
Completed	`NCT04227652` - Control of Fever in Septic Patients	N/A
Recruiting	`NCT04005001` - Machine Learning Sepsis Alert Notification Using Clinical Data	Phase 2
Recruiting	`NCT02899143` - Short-course Antimicrobial Therapy in Sepsis	Phase 2
Completed	`NCT02539147` - Characterization of Non-canonical Way in Inflammasome Monocytes of Patients With Severe Sepsis	N/A
Completed	`NCT01932814` - Acute Kidney Injury in Septic Critically Ill Patients : Are Aminoglycosides Really Harmful?	N/A
Completed	`NCT01929772` - German Lactat Clearance in Severe Sepsis	N/A
Completed	`NCT01449721` - Preemptive Resuscitation for Eradication of Septic Shock	N/A
Active, not recruiting	`NCT01162109` - Zinc Therapy in Critical Illness	Phase 1
Not yet recruiting	`NCT01211899` - 4G/5G Polymorphism of Plasminogen Activator Inhibitor-1 Gene and Disseminated Intravascular Coagulation in Severe Sepsis and Septic Shock	N/A
Completed	`NCT00934011` - Use of Inflammatory Biomarkers to Guide Antibiotic Therapy in Patients With Severe Infections	N/A
Recruiting	`NCT00335907` - Protocol-driven Hemodynamic Support for Patients With Septic Shock	N/A
Completed	`NCT00463645` - Investigation of Correlation Between Interstitial and Arterial Blood Glucose Concentrations in Septic Patients	N/A
Completed	`NCT02361528` - GM-CSF to Decrease ICU Acquired Infections	Phase 3
Completed	`NCT02734550` - (1,3)-β-D-glucan Based Diagnosis of Invasive Candida Infection in Sepsis	N/A
Completed	`NCT02973243` - The Vital Signs to Identify, Target, and Assess Level (VITAL) Care Study III	N/A
Terminated	`NCT03895853` - Early Metabolic Resuscitation for Septic Shock	Phase 2
Completed	`NCT01945983` - Early Use of Norepinephrine in Septic Shock Resuscitation	N/A
Completed	`NCT01598831` - Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy	Phase 3
Enrolling by invitation	`NCT02258984` - Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial	N/A

NCT number	NCT02739373
Study type	Interventional
Source	Bristol-Myers Squibb
Contact
Status	Completed
Phase	Phase 1
Start date	April 18, 2016
Completion date	December 14, 2016

Pharmacokinetics, Safety, Tolerability and Pharmacodynamics of BMS-986189 in Healthy Subjects

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms